Paul Woitach

Managing Partner, Pharmaceutical Advisors

Paul Woitach is Managing Partner of Pharmaceutical Advisors LLC, a consulting firm that provides product development, technical due diligence, market opportunity assessment &  valuation support for clients in various Life Sciences industries.  The company helps clients accelerate progress and manage risk through an integrated approach to drug R&D and Commercialization.  Mr. Woitach helped found the Advisors business in 2001 while he was President of Pharma Service Ventures within Solutia, Inc. The business was acquired from Solutia by Pharmaceutical Advisors LLC in 2005.

Prior to Solutia, Mr. Woitach led a turnaround effort as President and CEO of Immunogenetics / IGI, Inc. a manufacturer of controlled release drug delivery technology, animal pharmaceuticals, biologicals and human dermatology products.  As part of that effort, Mr. Woitach completed nearly $48MM in debt financings and refinancings, concluded a number of licensing arrangements and divested Divisions of the company.   Before that, he was General Manager, North America with laboratory instrument manufacturer Mettler Toledo.  He also spent 16 years with Eastman Kodak where he was a Vice President and Executive Director with the $2B Health Imaging Division.  Mr. Woitach has served on the Board of Directors and Audit Committee of public companies, Rheometric Scientific and Proterion and he has served as a Director, HealthSPAC Pharmaceutical Services, Inc, London & Pacific Healthcare, Inc. (OTCPK: LDPH).  He is on the Advisory Boards of the business incubator at the New Jersey Economic Development Authority Center for Commercialization of Innovative Technology and has served on the Advisory board of the Hackensack University Medical Center Life Sciences Institute. Mr. Woitach also serves on the Montgomery Township Zoning Board of Adjustment and has served as the President of Montgomery Cougar Football in Montgomery, NJ.

Mr. Woitach is a native of New York City and holds an MBA from the William E. Simon School of Business.  He has lectured at the Principles & Practices of Drug Development program at the Sloan School at MIT and has led various courses in Bio-Processing and pharmaceutical outsourcing for ASME and IQPC and other organizations.